Lung cancer is one of the most common malignant diseases. Many tests and techniques are used in the staging of this disease, including positron emission tomography. This is probably the most recently introduced test and is capable of providing information on all the structures affected by malignancy. We present a case of a false positive result due to increased splenic uptake of the tracer.
HernándezJ.R., IzarzuagaM.I.: Epidemiología del cáncer de pulmón en España. In: de pulmónCáncer, López EncuentraA., Llobregat PoyánN. (Eds), Monografías NEUMOMADRID, Ediciones Doyma, Barcelona, 2002.
2.
GarbayoA.J., VillafrancaE., De BlasA., TejeroA., EslavaE., ManterolaA., RomeroP., MartinezM.: Metastatic bone disease. Diagnosis and treatment.An Sist Sanit Navar,27(Suppl 3): 137–153, 2004.
3.
PugatchR.D.: Radiologic evaluation in chest malignancies. A review of imaging modalities.Chest,107(6 Suppl): 294S–297S, 1995.
4.
VerschakelenJ.A., De WeverW., BogaertJ.: Role of computed tomography in lung cancer staging.Curr Opin Pulm Med,10: 248–255, 2004.
5.
RobertsP.F., FolletteD.M., Von HaagD., ParkJ.A., ValkP.E., PoundsT.R., HopkinsD.M.: Factors associated with false-positive staging of lung cancer by positron emission tomography.Ann Thorac Surg,70: 1154–1159, 2000.
